Stroke

Showing NaN - NaN of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Atrial Fibrillation, Stroke Trial in Worldwide (Rivaroxaban, Acetylsalicylic acid)

Recruiting
  • Atrial Fibrillation
  • Stroke
  • Canberra, Australian Capital Territory, Australia
  • +54 more
Mar 23, 2022

Atrial Fibrillation, Stroke Trial in Worldwide (Apixaban, aspirin)

Active, not recruiting
  • Atrial Fibrillation
  • Stroke
  • Mesa, Arizona
  • +129 more
Aug 25, 2021

GLORIA-AF Registry Program - Second and Third Phases

Completed
  • Stroke
  • Atrial Fibrillation
    • Mobile, Alabama
    • +665 more
    Mar 3, 2021

    Stroke, Myocardial Infarction, Diabetes Trial in Worldwide (pioglitazone, )

    Completed
    • Stroke
    • +2 more
    • Birmingham, Alabama
    • +182 more
    Apr 14, 2020

    Stroke, Secondary Prevention Trial in Worldwide (optional ASA as comedication, to ASA, to optional ASA as comedication)

    Completed
    • Stroke
    • Secondary Prevention
    • optional ASA as comedication
    • +5 more
    • Phoenix, Arizona
    • +568 more
    Aug 13, 2019

    Atrial Fibrillation, Stroke Trial in Worldwide (warfarin, Dabigatran dose 1, Dabigatran dose 2)

    Completed
    • Atrial Fibrillation
    • Stroke
    • Birmingham, Alabama
    • +983 more
    Apr 8, 2019

    Stroke, Atrial Fibrillation, Embolism Trial in Worldwide (warfarin tablets, Edoxaban tablets (high dose regimen-60mg), Edoxaban

    Completed
    • Stroke
    • +2 more
    • warfarin tablets
    • +4 more
    • Birmingham, Alabama
    • +1015 more
    Feb 8, 2019

    Stroke Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Acetylsalicylic acid (Aspirin, BAY1019036), Rivaroxaban-Placebo)

    Terminated
    • Stroke
    • Rivaroxaban (Xarelto, BAY59-7939)
    • +3 more
    • Tucson, Arizona
    • +453 more
    Dec 20, 2018

    Stroke, Transient Ischemic Attack, Atrial Fibrillation Trial in Canada (a 30-day ambulatory cardiac event monitor, 24-hour

    Unknown status
    • Stroke
    • +3 more
    • a 30-day ambulatory cardiac event monitor
    • 24-hour Holter
    • Calgary, Alberta, Canada
    • +16 more
    Oct 3, 2018

    Stroke Trial in Canada (rfVIIa, Standard saline solution)

    Completed
    • Stroke
    • rfVIIa
    • Standard saline solution
    • Calgary, Alberta, Canada
    • +14 more
    Oct 3, 2018

    Stroke Trial in Kelowna, Vancouver, Victoria (Education manual, An inpatient homework based exercise program for the upper limb

    Completed
    • Stroke
    • Education manual
    • An inpatient homework based exercise program for the upper limb post stroke
    • Kelowna, British Columbia, Canada
    • +3 more
    May 8, 2017

    Stroke Trial in Worldwide (Desmoteplase, Placebo)

    Terminated
    • Stroke
    • Phoenix, Arizona
    • +151 more
    Feb 8, 2017

    Stroke Trial in Canada, United States (V10153)

    Completed
    • Stroke
    • Scottsdale, Arizona
    • +27 more
    May 4, 2016

    Myocardial Infarction, Cardiovascular Death, Atherothrombosis Trial in Worldwide (Ticagrelor 90 mg, Ticagrelor 60 mg, Ticagrelor

    Completed
    • Myocardial Infarction
    • +3 more
    • Ticagrelor 90 mg
    • +2 more
    • Alexander City, Alabama
    • +846 more
    Dec 18, 2015

    Stroke Trial in Worldwide (SUN13837, )

    Withdrawn
    • Stroke
    • Mobile, Alabama
    • +52 more
    Oct 19, 2015

    Stroke Trial in Victoria (Arm and Leg Cycling Exercise Program)

    Unknown status
    • Stroke
    • Arm and Leg Cycling Exercise Program
    • Victoria, British Columbia, Canada
      Rehabilitation Neuroscience Laboratory
    Sep 2, 2014

    Stroke Trial in Worldwide (Aggrenox, Clopidogrel , Micardis)

    Completed
    • Stroke
    • Birmingham, Alabama
    • +666 more
    Apr 22, 2014

    Stroke Trial in Worldwide (IV rt-PA alone, endovascular therapy)

    Terminated
    • Stroke
    • IV rt-PA alone
    • endovascular therapy
    • Birmingham, Alabama
    • +70 more
    Nov 19, 2013

    Stroke Trial in Canada, India (NTx™-265: rhCG, then rEPO, Saline )

    Terminated
    • Stroke
    • NTx™-265: rhCG, then rEPO
    • Saline placebo
    • Calgary, Alberta, Canada
    • +25 more
    Aug 10, 2009

    Stroke, Acute Ischemic Stroke Trial in Worldwide (Repinotan HCl (BAYX3702), Placebo)

    Completed
    • Stroke
    • Acute Ischemic Stroke
    • Repinotan HCl (BAYX3702)
    • Placebo
    • Los Angeles, California
    • +118 more
    Jun 9, 2009

    Transient Ischemic Attack, Stroke Trial in Canada, United States (Aspirin, Clopidogrel, Simvastatin)

    Completed
    • Transient Ischemic Attack
    • Stroke
    • Philadelphia, Pennsylvania
    • +17 more
    Apr 7, 2008